R01 CA232517/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2019	3
2020	7
2021	3
2022	5
2023	2
2024	3
2025	0

1

Patil VA, Masters KS. Patil VA, et al. Bioengineering (Basel). 2020 Dec 16;7(4):163. doi: 10.3390/bioengineering7040163. Bioengineering (Basel). 2020. PMID: 33339157 Free PMC article. Review.

2

Multispectral Staining and Analysis of Extracellular Matrix.

Renner CM, Visetsouk MR, Kreeger PK, Masters KS. Renner CM, et al. Methods Mol Biol. 2022;2424:105-119. doi: 10.1007/978-1-0716-1956-8_6. Methods Mol Biol. 2022. PMID: 34918289 Free PMC article.

3

Bioengineering Approaches to Improve Gynecological Cancer Outcomes.

Abbaspour A, Casillas AL, McGregor SM, Kreeger PK. Abbaspour A, et al. Curr Opin Biomed Eng. 2022 Jun;22:100384. doi: 10.1016/j.cobme.2022.100384. Epub 2022 Mar 30. Curr Opin Biomed Eng. 2022. PMID: 35874185 Free PMC article.

4

Matrisome AnalyzeR - a suite of tools to annotate and quantify ECM molecules in big datasets across organisms.

Petrov PB, Considine JM, Izzi V, Naba A. Petrov PB, et al. J Cell Sci. 2023 Sep 1;136(17):jcs261255. doi: 10.1242/jcs.261255. Epub 2023 Sep 4. J Cell Sci. 2023. PMID: 37555624 Free PMC article.

5

The Many Microenvironments of Ovarian Cancer.

Micek HM, Visetsouk MR, Fleszar AJ, Kreeger PK. Micek HM, et al. Adv Exp Med Biol. 2020;1296:199-213. doi: 10.1007/978-3-030-59038-3_12. Adv Exp Med Biol. 2020. PMID: 34185294 Free PMC article. Review.

6

New Views of Old Proteins: Clarifying the Enigmatic Proteome.

Burnum-Johnson KE, Conrads TP, Drake RR, Herr AE, Iyengar R, Kelly RT, Lundberg E, MacCoss MJ, Naba A, Nolan GP, Pevzner PA, Rodland KD, Sechi S, Slavov N, Spraggins JM, Van Eyk JE, Vidal M, Vogel C, Walt DR, Kelleher NL. Burnum-Johnson KE, et al. Mol Cell Proteomics. 2022 Jul;21(7):100254. doi: 10.1016/j.mcpro.2022.100254. Epub 2022 May 30. Mol Cell Proteomics. 2022. PMID: 35654359 Free PMC article.

7

Topological defects in the mesothelium suppress ovarian cancer cell clearance.

Zhang J, Yang N, Kreeger PK, Notbohm J. Zhang J, et al. APL Bioeng. 2021 Aug 3;5(3):036103. doi: 10.1063/5.0047523. eCollection 2021 Sep. APL Bioeng. 2021. PMID: 34396026 Free PMC article.

8

Model of collective detachment in high-grade serous ovarian cancer demonstrates that tumor spheroids produce ECM to support metastatic processes.

Micek HM, Rosenstock L, Ma Y, Hielsberg C, Montemorano L, Gari MK, Ponik SM, Kreeger PK. Micek HM, et al. APL Bioeng. 2023 Feb 28;7(1):016111. doi: 10.1063/5.0132254. eCollection 2023 Mar. APL Bioeng. 2023. PMID: 36875739 Free PMC article.

9

The role of Piezo1 mechanotransduction in high-grade serous ovarian cancer: Insights from an in vitro model of collective detachment.

Micek HM, Yang N, Dutta M, Rosenstock L, Ma Y, Hielsberg C, McCord M, Notbohm J, McGregor S, Kreeger PK. Micek HM, et al. Sci Adv. 2024 Apr 26;10(17):eadl4463. doi: 10.1126/sciadv.adl4463. Epub 2024 Apr 26. Sci Adv. 2024. PMID: 38669327 Free PMC article.

10

Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2/STAT3 pathway.

Fogg KC, Olson WR, Miller JN, Khan A, Renner C, Hale I, Weisman PS, Kreeger PK. Fogg KC, et al. Cancer Lett. 2019 Aug 28;458:92-101. doi: 10.1016/j.canlet.2019.05.029. Epub 2019 May 24. Cancer Lett. 2019. PMID: 31129149 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year